A case of vitiligo after COVID-19 vaccination: a possible role of thymic dysfunction

Aktas H, Ertuğrul G, 2022. Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence? Clin Exp Dermatol, 47(1):143–144. https://doi.org/10.1111/ced.14842 Amiri-Dashatan N, Koushki M, Parsamanesh N, et al., 2022. Serum cortisol concentration and COVID-19 severity: a systematic review and meta-analysis. J Invest Med, 70(3):766–772. https://doi.org/10.1136/jim-2021-001989 Arora J, Wang JP, Weaver V, et al., 2022. Novel insight into the role of the vitamin D receptor in the development and function of the immune system. J Steroid Biochem Mol Biol, 219:106084. https://doi.org/10.1016/j.jsbmb.2022.106084 Ashwell JD, Lu FWM, Vacchio MS, 2000. Glucocorticoids in T cell development and function. Annu Rev Immunol, 18:309–345. https://doi.org/10.1146/annurev.immunol.18.1.309 Aygun H, 2022. Vitamin D can reduce severity in COVID-19 through regulation of PD-L1. Naunyn-Schmiedeberg’s Arch Pharmacol, 395(4):487–494. https://doi.org/10.1007/s00210-022-02210-w Baecher-Allan C, Brown JA, Freeman GJ, et al., 2001. CD4+CD25high regulatory cells in human peripheral blood. J Immunol, 167(3):1245–1253. https://doi.org/10.4049/jimmunol.167.3.1245 Barthlott T, Moncrieffe H, Veldhoen M, et al., 2005. CD25+CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. Int Immunol, 17(3):279–288. https://doi.org/10.1093/intimm/dxh207 Block JP, Boehmer TK, Forrest CB, et al., 2022. Cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination—PCORnet, United States, January 2021–January 2022. MMWR Morb Mortal Wkly Rep, 71(14):517–523. https://doi.org/10.15585/mmwr.mm7114e1 Bukhari AE, 2022. New-onset of vitiligo in a child following COVID-19 vaccination. JAAD Case Rep, 22:68–69. https://doi.org/10.1016/j.jdcr.2022.02.021 Caroppo F, Deotto ML, Tartaglia J, et al., 2022. Vitiligo worsened following the second dose of mRNA SARS-CoV-2 vaccine. Dermatol Ther, 35(6):e15434. https://doi.org/10.1111/dth.15434 Carter JA, Strömich L, Peacey M, et al., 2022. Transcriptomic diversity in human medullary thymic epithelial cells. Nat Commun, 13:4296. https://doi.org/10.1038/S41467-022-31750-1 Chen JR, Li SL, Li CY, 2021. Mechanisms of melanocyte death in vitiligo. Med Res Rev, 41(2):1138–1166. https://doi.org/10.1002/med.21754 Ciccarese G, Drago F, Boldrin S, et al., 2022. Sudden onset of vitiligo after COVID-19 vaccine. Dermatol Ther, 35(1):e15196. https://doi.org/10.1111/dth.15196 Cordell W, 2020. The mechanisms linking relative hypercortisolism—the common feature across COVID-19 risks—to ARDS, septic shock, and cytokine dysregulation. SSRN, preprint. https://doi.org/10.2139/ssrn.3721693 Cui TT, Zhang WG, Li SL, et al., 2019. Oxidative stress–induced HMGB1 release from melanocytes: a paracrine mechanism underlying the cutaneous inflammation in vitiligo. J Invest Dermatol, 139(10):2174–2184.e4. https://doi.org/10.1016/j.jid.2019.03.1148 Daniels MA, Teixeiro E, Gill J, et al., 2006. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature, 444(7120):724–729. https://doi.org/10.1038/nature05269 Drabkin MJ, Meyer JI, Kanth N, et al., 2018. Age-stratified patterns of thymic involution on multidetector CT. J Thorac Imaging, 33(6):409–416. https://doi.org/10.1097/RTI.0000000000000349 Duggal NA, Upton J, Phillips AC, et al., 2015. NK cell immunesenescence is increased by psychological but not physical stress in older adults associated with raised cortisol and reduced perforin expression. AGE, 37:11. https://doi.org/10.1007/s11357-015-9748-2 Dumont-Lagacé M, St-Pierre C, Perreault C, 2015. Sex hormones have pervasive effects on thymic epithelial cells. Sci Rep, 5:12895. https://doi.org/10.1038/srep12895 Fahy GM, Brooke RT, Watson JP, et al., 2019. Reversal of epigenetic aging and immunosenescent trends in humans. Aging cell, 18(6):e13028. https://doi.org/10.1111/acel.13028 Gordon SM, Chaix J, Rupp LJ, et al., 2012. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity, 36(1):55–67. https://doi.org/10.1016/j.immuni.2011.11.016 Grant WB, al Anouti F, Boucher BJ, et al., 2022. A narrative review of the evidence for variations in serum 25-hydroxyvitamin D concentration thresholds for optimal health. Nutrients, 14(3):639. https://doi.org/10.3390/nu14030639 Handel AE, Irani SR, Holländer GA, 2018. The role of thymic tolerance in CNS autoimmune disease. Nat Rev Neurol, 14(12):723–734. https://doi.org/10.1038/s41582-018-0095-7 Haseeb AA, Solyman O, Abushanab MM, et al., 2022. Ocular complications following vaccination for COVID-19: a one-year retrospective. Vaccines, 10(2):342. https://doi.org/10.3390/vaccines10020342 Herzum A, Micalizzi C, Molle MF, et al., 2022. New-onset vitiligo following COVID-19 disease. Skin Health Dis, 2(1):e86. https://doi.org/10.1002/ski2.86 Huda MN, Ahmad SM, Alam J, et al., 2019. Infant cortisol stress–response is associated with thymic function and vaccine response. Stress, 22(1):36–43. https://doi.org/10.1080/10253890.2018.1484445 Hüe S, Monteiro RC, Berrih-Aknin S, et al., 2003. Potential role of NKG2D/MHC class I-related chain A interaction in intrathymic maturation of single-positive CD8 T cells. J Immunol, 171(4):1909–1917. https://doi.org/10.4049/jimmunol.171.4.1909 Jacquemin C, Rambert J, Guillet S, et al., 2017. Heat shock protein 70 potentiates interferon alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis. Br J Dermatol, 177(5):1367–1375. https://doi.org/10.1111/bjd.15550 Jacquemin C, Martins C, Lucchese F, et al., 2020. NKG2D defines a subset of skin effector memory CD8 T cells with proinflammatory functions in vitiligo. J Invest Dermatol, 140(6):1143–1153.e5. https://doi.org/10.1016/j.jid.2019.11.013 Kaminetsky J, Rudikoff D, 2021. New-onset vitiligo following mRNA-1273 (Moderna) COVID-19 vaccination. Clin Case Rep, 9(9):e04865. https://doi.org/10.1002/ccr3.4865 Kim K, Bang SY, Ikari K, et al., 2016. Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis. Sci Rep, 6:27563. https://doi.org/10.1038/srep27563 Koç Yıldırım S, 2022. A new-onset vitiligo following the inactivated COVID-19 vaccine. J Cosmet Dermatol, 21(2):429–430. https://doi.org/10.1111/jocd.14677 Krüger C, Schallreuter KU, 2012. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol, 51(10):1206–1212. https://doi.org/10.1111/j.1365-4632.2011.05377.x le Vu S, Bertrand M, Jabagi MJ, et al., 2022. Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines. Nat Commun, 13:3633. https://doi.org/10.1038/s41467-022-31401-5 Liu CX, Yan SX, Chen HZ, et al., 2021. Association of GTF2I, NFKB1, and TYK2 regional polymorphisms with systemic sclerosis in a Chinese Han population. Front Immunol, 12:640083. https://doi.org/10.3389/fimmu.2021.640083 López Riquelme I, Fernández Ballesteros MD, Serrano Ordoñez A, et al., 2022. COVID-19 and autoimmune phenomena: vitiligo after Astrazeneca vaccine. Dermatol Ther, 35(7):e15502. https://doi.org/10.1111/dth.15502 Macca L, Peterle L, Ceccarelli M, et al., 2022. Vitiligo-like lesions and COVID-19: case report and review of vaccination- and infection-associated vitiligo. Vaccines, 10(10):1647. https://doi.org/10.3390/vaccines10101647 Mahdavi MRV, Ardestani SK, Rezaei A, et al., 2021. COVID-19 patients suffer from DHEA-S sufficiency. Immunoregulation, 3(2):135–144. https://doi.org/10.32598/Immunoregulation.3.2.5 Manti PG, Trattaro S, Castaldi D, et al., 2022. Thymic stroma and TFII-I: towards new targeted therapies. Trends Mol Med, 28(1):67–78. https://doi.org/10.1016/j.molmed.2021.10.008 Nakamagoe K, Furuta JI, Shioya A, et al., 2009. A case of vitiligo vulgaris showing a pronounced improvement after treatment for myasthenia gravis. BMJ Case Rep, 2009:bcr07.2009.2091. https://doi.org/10.1136/bcr.07.2009.2091 Nicolaidou E, Vavouli C, Koumprentziotis IA, et al., 2023. New-onset vitiligo after COVID-19 mRNA vaccination: a causal association? J Eur Acad Dermatol Venereol, 37(1):e11–e12. https://doi.org/10.1111/jdv.18513 Nimer RM, Khabour OF, Swedan SF, et al., 2022. The impact of vitamin and mineral supplements usage prior to COVID-19 infection on disease severity and hospitalization. Bosn J Basic Med Sci, 22(5):826–832. https://doi.org/10.17305/bjbms.2021.7009 Nyce J, 2021. Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19. Endocr-Relat Cancer, 28(2):R47–R53. https://doi.org/10.1530/ERC-20-0439 Paolino M, Koglgruber R, Cronin SJF, et al., 2021. RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy. Nature, 589(7842):442–447. https://doi.org/10.1038/s41586-020-03071-0 Post NF, Luiten RM, Wolkerstorfer A, et al., 2021. Does autoimmune vitiligo protect against COVID-19 disease? Exp Dermatol, 30(9):1254–1257. https://doi.org/10.1111/exd.14407 Qiao JJ, Zhou GG, Ding YG, et al., 2011. Multiple paraneoplastic syndromes: myasthenia gravis, vitiligo, alopecia areata, and oral lichen planus associated with thymoma. J Neurol Sci, 308(1–2):177–179. https://doi.org/10.1016/j.jns.2011.05.038 Richmond JM, Frisoli ML, Harris JE, 2013. Innate immune mechanisms in vitiligo: danger from within. Curr Opin Immunol, 25(6):676–682. https://doi.org/10.1016/j.coi.2013.10.010 Schmidt AF, Rubin A, Milgraum D, et al., 2022. Vitiligo following COVID-19: a case report and review of pathophysiology. JAAD Case Rep, 22:47–49. https://doi.org/10.1016/j.jdcr.2022.01.030 Seal KH, Bertenthal D, Carey E, et al., 2022. Association of vitamin D status and COVID-19-related hospitalization and mortality. J Gen Intern Med, 37(4):853–861. https://doi.org/10.1007/s11606-021-07170-0 Shilov ES, Gorshkova EA, Minnegalieva AR, et al., 2019. Splicing pattern of mRNA in thymus epithelial cells limits the transcriptome available for negative selection of autoreactive T cells. Mol Biol, 53(1):87–96. https://doi.org/10.1134/S0026893319010151 Singh R, Cohen JL, Astudillo M, et al., 2022. Vitiligo of the arm after COVID-19 vaccination. JAAD Case Rep, 28:142–144. https://doi.org/10.1016/j.jdcr.2022.06.003 Speeckaert R, van Geel N, 2017. Vitiligo: an update on pathophysiology and treatment options. Am J Clin Dermatol, 18(6):733–744. https://doi.org/10.1007/s40257-017-0298-5 Strindhall J, Nilsson BO, Löfgren S, et al., 2007. No immune risk profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp Gerontol, 42(8):753–761. https://doi.org/10.1016/j.exger.2007.05.001 Thapa P, Farber DL, 2019. The role of the thymus in the immune response. Thorac Surg Clin, 29(2):123–131. https://doi.org/10.1016/j.thorsurg.2018.12.001 Tulic MK, Cavazza E, Cheli Y, et al., 2019. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo. Nat Commun, 10:2178. https://doi.org/10.1038/s41467-019-09963-8 Uğurer E, Sivaz O, Altunay İK, 2022. Newly-developed vitiligo following COVID-19 mRNA vaccine. J Cosmet Dermatol, 21(4):1350–1351. https://doi.org/10.1111/jocd.14843 Warren S, Nehal K, Querfeld C, et al., 2015. Graft-versus-host disease-like erythroderma: a manifestation of thymoma-associated multiorgan autoimmunity. J Cutan Pathol, 42(10):663–668. https://doi.org/10.1111/cup.12642